Troriluzole: Clinical Trials

5 trials of Troriluzole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 terminated. 5 Phase 2, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Recruiting 1, Terminated 1
Phase 33Completed 2, Recruiting 1

Follow Troriluzole: new trials by email Literature Review of Troriluzole trials Research Report on Troriluzole

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets
Ipilimumab, Nivolumab, Troriluzole - Melanoma, Metastatic Melanoma
Phase 2TerminatedDana-Farber Cancer Institute12021-06-302024-03-26
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Temozolomide, Lomustine, Regorafenib - Glioblastoma
Phase 2 / Phase 3RecruitingGlobal Coalition for Adaptive Research22502019-07-302026-11-02
Study of BHV-4157 in Alzheimer's Disease
troriluzole, Placebo oral capsule - Alzheimer Disease
Phase 2CompletedBiohaven Pharmaceuticals, Inc.3502018-07-312023-12-06
Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder
Troriluzole, Placebo - Obsessive-Compulsive Disorder
Phase 2 / Phase 3CompletedBiohaven Pharmaceuticals, Inc.4262017-12-192026-01-22
Trial in Adult Participants With Spinocerebellar Ataxia (SCA)
Troriluzole, Placebo - Spinocerebellar Ataxias, Spinocerebellar Ataxia Genotype Type 1
Phase 2 / Phase 3CompletedBiohaven Pharmaceuticals, Inc.1412016-12-152025-10-08

Conditions studied

Alzheimer Disease (1)  ·  Glioblastoma (1)  ·  Melanoma (1)  ·  Obsessive-Compulsive Disorder (1)  ·  Recurrence (1)  ·  Spinocerebellar Ataxias (1)

Sponsors

Biohaven Pharmaceuticals, Inc. (3)  ·  Dana-Farber Cancer Institute (1)  ·  Global Coalition for Adaptive Research (1)

Countries

United States (5)  ·  Australia (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Switzerland (1)

Top investigators

Ann W Silk, MD, MS (1)  ·  Tim Cloughesy, MD (1)

Results publications

PMID 34115419, PMID 38773224, PMID 39462179, PMID 40317057, PMID 41980234